(Q47664479)

4 February 2018

title

Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice (English)

1 reference

4 February 2018

0 references

0 references

Basso B

1

1 reference

4 February 2018

Cervetta L

2

1 reference

4 February 2018

Moretti E

3

1 reference

4 February 2018

Carlier Y

4

1 reference

4 February 2018

Truyens C

5

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

22

1 reference

4 February 2018

issue

15-16

1 reference

4 February 2018

page(s)

1868-1872

1 reference

4 February 2018

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Field trial of vaccination against American trypanosomiasis (Chagas' disease) in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

The taxonomic position and evolutionary relationships of Trypanosoma rangeli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Trypanosoma rangeli sialidase: cloning, expression and similarity to T. cruzi trans-sialidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Antibodies against Trypanosoma cruzi in mice infected with T. rangeli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Current status of immune mechanisms of killing of intracellular microorganisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Immunosuppression induced by nitric oxide and its inhibition by interleukin-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

inferred from DOI database lookup

7 January 2021

based on heuristic

High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-alpha gene transcription in their offspring

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.11.013

1 reference

4 February 2018

release_jeuqj65kjvbptfdu7ku6nhqcta

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jeuqj65kjvbptfdu7ku6nhqcta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 February 2018